Utilizing Targeted Agents for Treatment of HFrEF: The Role of the Pharmacist in Medication Selection and Therapy Management
1.0 Credit / Cardiology
View More
Advances in the Treatment of Metastatic Renal Cell Carcinoma: New Horizons in Targeted Therapies
View More
Optimizing Asparaginase Use in Acute Lymphoblastic Leukemia: A Comprehensive Program on Safety and Efficacy
View More
Integrating Sphingosine-1-Phosphate (S1P) Receptor Modulators in the Management of Ulcerative Colitis: The Pharmacist’s Role on the Interdisciplinary Team
1.5 Credits / Gastroenterology, Immunology
View More
Exploring the Evolving Treatment Landscape for Patients With Waldenström Macroglobulinemia
0.75 Credit / Oncology
View More
The Role of Immune Checkpoint Inhibitors in Cutaneous Melanoma: Evaluating Therapeutic Trends
0.75 Credit / Oncology
View More
Updates on the Utility of PARP Inhibitors in the Treatment of Ovarian Cancer: Opportunities for Pharmacists to Improve Patient Care
0.75 Credit / Oncology, Women's Health
View More
Optimizing Care of Patients on Immune Checkpoint Inhibitors: An Oncology Primer for Community Pharmacists
1.25 Credits / Oncology
View More
COPD Exacerbations Reduced Substantially With Dupilumab, Phase 3 Data Shows
The NOTUS trial was shown to have successfully achieved its primary endpoint, demonstrating the notable efficacy of dupilumab in reducing exacerbations by 34% versus placebo in individuals with moderate-to-severe COPD showing evidence of type 2 inflammation.
Chronic Insufficient Sleep Associated With Increased Insulin in Women
November 23rd 2023While data has associated insufficient sleep with increased risks of hypertension, cardiovascular disease, and disordered glucose metabolism, a potential source of insulin resistance and type 2 diabetes, much of this data was performed on male participants or evaluated short-term sleep restriction.
Women With Endometriosis More Likely to Experience Mental Health, Menstrual, Pain Symptoms
November 17th 2023Women with endometriosis face an average of 7 to 11 years between the time of symptom onset and diagnosis, during which they experience increased symptoms, hospitalizations, and health care resource utilization.